help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-1416
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murad, M. H.
Right arrow Articles by Montori, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murad, M. H.
Right arrow Articles by Montori, V. M.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 3 741-745
Copyright © 2009 by The Endocrine Society


CLINICAL REVIEW

Drug-Induced Hypoglycemia: A Systematic Review

M. Hassan Murad, Fernando Coto-Yglesias, Amy T. Wang, Nasim Sheidaee, Rebecca J. Mullan, Mohamed B. Elamin, Patricia J. Erwin and Victor M. Montori

Division of Preventive Medicine (M.H.M.), Knowledge and Encounter Research Unit (M.H.M., F.C.-Y., A.T.W., N.S., R.J.M., M.B.E., P.J.E., V.M.M.), and Department of Medicine (M.H.M., A.T.W., V.M.M.), Mayo Clinic, Rochester, Minnesota 55905; Hospital Nacional de Geriatria y Gerontologia (F.C.-Y.), Caja Costarricense Seguro Social, San José, Costa Rica; and Division of Endocrinology (V.M.M.), Diabetes, Metabolism, Nutrition, Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Victor M. Montori, M.D., M.Sc., Mayo Clinic, W18A, 200 First Street SW, Rochester, Minnesota 55905. E-mail: montori.victor{at}mayo.edu.

Context: Drug-induced hypoglycemia is a significant adverse effect that may cause important morbidity.

Objective: The aim of the study was to systematically review the literature for drugs reported to cause hypoglycemia and assess the quality of evidence and strength of association supporting this causal link.

Data Sources: We searched electronic databases (MEDLINE, EMBASE, Web of Science, and SCOPUS) and the drug information system Micromedex through November 2007 and sought additional references from experts.

Study Selection: Studies were eligible if they reported hypoglycemia as a side effect of a drug not used to treat hyperglycemia, regardless of their design, language, size, or follow-up duration. We excluded hypoglycemia caused by industrial exposures, nonpharmacological chemical exposures, alcohol, herbs, nutritional supplements, and in vitro and animal studies.

Data Extraction: Reviewers extracted study characteristics and methodological quality and, when possible, data to estimate the odds of developing hypoglycemia when exposed to the offending agent.

Data Synthesis: We found 448 eligible studies that described 2696 cases of hypoglycemia associated with 164 different drugs. The quality of evidence supporting associations between drugs and hypoglycemia was mostly very low due to methodological limitations and imprecision. The most commonly reported offending drugs were quinolones, pentamidine, quinine, beta blockers, angiotensin-converting enzyme agents, and IGF.

Conclusions: Very low quality evidence substantiates the association between hypoglycemia and the use of numerous nondiabetic drugs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society